Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
- PMID: 21796619
- DOI: 10.1002/ijc.26317
Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas
Abstract
Neuroblastoma is an aggressive embryonal tumor that accounts for ∼15% of childhood cancer deaths. Hitherto, despite the availability of comprehensive genomic data on DNA copy number changes in neuroblastoma, relatively little is known about the genes driving neuroblastoma tumorigenesis. In this study, high resolution array comparative genome hybridization (CGH) was performed on 188 primary neuroblastoma tumors and 33 neuroblastoma cell lines to search for previously undetected recurrent DNA copy number gains and losses. A new recurrent distal chromosome 1q deletion (del(1)(q42.2qter)) was detected in seven cases. Further analysis of available array CGH datasets revealed 13 additional similar distal 1q deletions. The majority of all detected 1q deletions was found in high risk 11q deleted tumors without MYCN amplification (Fisher exact test p = 5.61 × 10(-5) ). Using ultra-high resolution (∼115 bp resolution) custom arrays covering the breakpoints on 1q for 11 samples, clustering of nine breakpoints was observed within a 12.5-kb region, of which eight were found in a 7-kb copy number variable region, whereas the remaining two breakpoints were colocated 1.4-Mb proximal. The commonly deleted region contains one miRNA (hsa-mir-1537), four transcribed ultra conserved region elements (uc.43-uc.46) and 130 protein coding genes including at least two bona fide tumor suppressor genes, EGLN1 (or PHD2) and FH. This finding further contributes to the delineation of the genomic profile of aggressive neuroblastoma, offers perspectives for the identification of genes contributing to the disease phenotype and may be relevant in the light of assessment of response to new molecular treatments.
Copyright © 2011 UICC.
Similar articles
-
Constitutional 11q14-q22 chromosome deletion syndrome in a child with neuroblastoma MYCN single copy.Eur J Med Genet. 2013 Nov;56(11):626-34. doi: 10.1016/j.ejmg.2013.08.005. Epub 2013 Sep 13. Eur J Med Genet. 2013. PMID: 24035971
-
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.BMC Genomics. 2008 Jul 29;9:353. doi: 10.1186/1471-2164-9-353. BMC Genomics. 2008. PMID: 18664255 Free PMC article.
-
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.Med Pediatr Oncol. 2003 Jul;41(1):30-5. doi: 10.1002/mpo.10313. Med Pediatr Oncol. 2003. PMID: 12764740
-
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.Med Pediatr Oncol. 2001 Jan;36(1):52-5. doi: 10.1002/1096-911X(20010101)36:1<52::AID-MPO1014>3.0.CO;2-8. Med Pediatr Oncol. 2001. PMID: 11464906 Review.
-
11q deletion in neuroblastoma: a review of biological and clinical implications.Mol Cancer. 2017 Jun 29;16(1):114. doi: 10.1186/s12943-017-0686-8. Mol Cancer. 2017. PMID: 28662712 Free PMC article. Review.
Cited by
-
Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes.Cancers (Basel). 2023 Dec 7;15(24):5732. doi: 10.3390/cancers15245732. Cancers (Basel). 2023. PMID: 38136279 Free PMC article.
-
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism.Br J Cancer. 2023 Nov;129(10):1546-1557. doi: 10.1038/s41416-023-02412-w. Epub 2023 Sep 9. Br J Cancer. 2023. PMID: 37689804 Free PMC article. Review.
-
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer.Biomolecules. 2023 Jun 5;13(6):944. doi: 10.3390/biom13060944. Biomolecules. 2023. PMID: 37371524 Free PMC article. Review.
-
Connections between metabolism and epigenetics: mechanisms and novel anti-cancer strategy.Front Pharmacol. 2022 Jul 22;13:935536. doi: 10.3389/fphar.2022.935536. eCollection 2022. Front Pharmacol. 2022. PMID: 35935878 Free PMC article. Review.
-
The epigenetic-metabolic interplay in gliomagenesis.Open Biol. 2022 Apr;12(4):210350. doi: 10.1098/rsob.210350. Epub 2022 Apr 6. Open Biol. 2022. PMID: 35382567 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous